Induction and coexpression of latent transforming growth factor β-binding protein-1 and fibrillin-1 in experimental glomerulonephritis

Nephron - Experimental Nephrology

Volumn 102, Issue 3-4, 2006, Pages

  Porst, Markus ^a   Daniel, Christoph ^a   Plank, Christian ^a   Schocklmann, Harald O ^b   Reinhardt, Dieter P ^c   Hartner, Andrea ^a,d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Anti Thy1.1 nephritis; Extracellular matrix; Glomerulus; Mesangial cells; Microfibrillar proteins; Transforming growth factor

Indexed keywords

BINDING PROTEIN; FIBRILLIN 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; MESSENGER RNA; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, THY-1; GLOMERULONEPHRITIS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY GLOMERULUS; LATENT TGF-BETA BINDING PROTEINS; MALE; MICROFILAMENT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 33344477601     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089688     Document Type: Article

References (17)

1. Saharinen J, Hyytiainen M, Taipale J, Keski-Oja J: Latent transforming growth factor-beta binding proteins (LTBPs) - structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev 1999;10:99-117.
2. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF: Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol 1995;131:539-549.
3. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY: Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 2003;278:2750-2757.
4. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, Dietz HC: TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004;114:1586-1592.
5. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC: Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407-411.
6. Sterzel RB, Hartner A, Schlotzer-Schrehardt U, Voit S, Hausknecht B, Doliana R, Colombatti A, Gibson MA, Braghetta P, Bressan GM: Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int 2000;58:1588-1602.
7. Hartner A, Hilgers KF, Bitzer M, Veelken R, Schocklmann HO: Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis. J Mol Med 2003;81:32-42.
8. Minto AW, Wilson HM, Rees AJ, Quigg RJ, Brown PA: Selective expression of TGF-beta2 and TGF-beta3 isoforms in early mesangioproliferative glomerulonephritis. Nephron Exp Nephrol 2004;96:e111-e118.
9. Hartner A, Cordasic N, Klanke B, Muller U, Sterzel RB, Hilgers KF: The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol 2002;160:861-867.
10. Tiedemann K, Batge B, Muller PK, Reinhardt DP: Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly. J Biol Chem 2001;276:36035-36042.
11. Wada T, Hamakawa S, Hori Y, Kaname S, Shimizu S, Kurokawa K, Katoh T: Immunohistochemical localization of latent transforming growth factor-beta binding protein in IgA nephropathy. Kidney Int Suppl 1997;63:S182-S184.
12. Hori Y, Katoh T, Hirakata M, Joki N, Kaname S, Fukagawa M, Okuda T, Okashi H, Fujita T, Miyazono K, Kurokawa K: Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells. Kidney Int 1998;53:1616-1625.
13. Kielty CM, Wess TJ, Haston L, Ashworth JL, Sherratt MJ, Shuttleworth CA: Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. J Muscle Res Cell Motil 2002;23:581-596.
14. Schaefer L, Mihalik D, Babelova A, Krzyzankova M, Grone HJ, Iozzo RV, Young MF, Seidler DG, Lin G, Reinhardt DP, Schaefer RM: Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury. Am J Pathol 2004;165:383-396.
15. Sinha S, Heagerty AM, Shuttleworth CA, Kielty CM: Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 2002;53:971-983.
16. Schlotzer-Schrehardt U, Zenkel M, Kuchle M, Sakai LY, Naumann GO: Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 2001;73:765-780.
17. Saika S, Miyamoto T, Tanaka T, Ishida I, Ohnishi Y, Ooshima A: Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells. Br J Ophthalmol 2001;85:1362-1366.